The role of perivascular adipose tissue in vascular smooth muscle cell growth
- 10 January 2012
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 165 (3), 643-658
- https://doi.org/10.1111/j.1476-5381.2011.01404.x
Abstract
Adipose tissue is the largest endocrine organ, producing various adipokines and many other substances. Almost all blood vessels are surrounded by perivascular adipose tissue (PVAT), which has not received research attention until recently. This review will discuss the paracrine actions of PVAT on the growth of underlying vascular smooth muscle cells (VSMCs). PVAT can release growth factors and inhibitors. Visfatin is the first identified growth factor derived from PVAT. Decreased adiponectin and increased tumour necrosis factor-α in PVAT play a pathological role for neointimal hyperplasia after endovascular injury. PVAT-derived angiotensin II, angiotensin 1-7, reactive oxygen species, complement component 3, NO and H(2) S have a paracrine action on VSMC contraction, endothelial or fibroblast function; however, their paracrine actions on VSMC growth remain to be directly verified. Factors such as monocyte chemoattractant protein-1, interleukin-6, interleukin-8, leptin, resistin, plasminogen activator inhibitor type-1, adrenomedullin, free fatty acids, glucocorticoids and sex hormones can be released from adipose tissue and can regulate VSMC growth. Most of them have been verified for their secretion by PVAT; however, their paracrine functions are unknown. Obesity, vascular injury, aging and infection may affect PVAT, causing adipocyte abnormality and inflammatory cell infiltration, inducing imbalance of PVAT-derived growth factors and inhibitors, leading to VSMC growth and finally resulting in development of proliferative vascular disease, including atherosclerosis, restenosis and hypertension. In the future, using cell-specific gene interventions and local treatments may provide definitive evidence for identification of key factor(s) involved in PVAT dysfunction-induced vascular disease and thus may help to develop new therapies. This article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue-3.Keywords
This publication has 153 references indexed in Scilit:
- Matrix metalloproteinases modulated by protein kinase Cε mediate resistin-induced migration of human coronary artery smooth muscle cellsJournal of Vascular Surgery, 2011
- Age and sex mediated changes in epicardial fat adipokinesAtherosclerosis, 2010
- Crosstalk between perivascular adipose tissue and blood vesselsCurrent Opinion in Pharmacology, 2010
- Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritisArthritis & Rheumatism, 2010
- Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injuryAtherosclerosis, 2009
- Prevention of vasa vasorum neovascularization attenuates early neointima formation in experimental hypercholesterolemiaBasic Research in Cardiology, 2009
- Nonesterified fatty acid exposure activates protective and mitogenic pathways in vascular smooth muscle cells by alternate signaling pathwaysMetabolism, 2009
- Noninvasive Measurement of Carotid Extra-Media Thickness: Associations With Cardiovascular Risk Factors and Intima-Media ThicknessJACC: Cardiovascular Imaging, 2009
- Prevalence of Overweight and Obesity in the United States, 1999-2004Published by American Medical Association (AMA) ,2006
- The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cellsHeart and Vessels, 2004